BackGlobal Cord Blood Overview

Global Cord Blood Cost of Revenue

Cost of Revenue analysis for CO.

Quarterly Cost of Revenue

$41.98M
12.26% YoY

As of Jul 5, 2022

Annual Cost of Revenue (TTM)

$177.44M
3.21% YoY

Trailing 12 months ending Jul 5, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)